Follow
Mohammed Tikly
Mohammed Tikly
Verified email at wits.ac.za
Title
Cited by
Cited by
Year
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ...
Annals of the rheumatic diseases 69 (10), 1809-1815, 2010
15042010
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
P Emery, FC Breedveld, EM Lemmel, JP Kaltwasser, PT Dawes, B Gömör, ...
Rheumatology 39 (6), 655-665, 2000
6552000
Mapping and predicting mortality from systemic sclerosis
M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ...
Annals of the rheumatic diseases 76 (11), 1897-1905, 2017
5402017
Chorea in the antiphospholipid syndrome-Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature
R Cervera, RA Asherson, J Font, M Tikly, L Pallares-Ferreres, A Chamorro, ...
Medicine 76 (3), 203-212, 1997
3081997
Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study
VK Jaeger, EG Wirz, Y Allanore, P Rossbach, G Riemekasten, E Hachulla, ...
PloS one 11 (10), e0163894, 2016
2232016
Digital ulcers predict a worse disease course in patients with systemic sclerosis
C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ...
Annals of the rheumatic diseases 75 (4), 681-686, 2016
1792016
Causes and predictors of death in South Africans with systemic lupus erythematosus
S Wadee, M Tikly, M Hopley
Rheumatology 46 (9), 1487-1491, 2007
1652007
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic …
TB Niewold, JA Kelly, SN Kariuki, BS Franek, AA Kumar, KM Kaufman, ...
Annals of the rheumatic diseases 71 (3), 463-469, 2012
1582012
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
J Avouac, UA Walker, E Hachulla, G Riemekasten, G Cuomo, PE Carreira, ...
Annals of the rheumatic diseases 75 (1), 103-109, 2016
1552016
Rheumatoid arthritis in the developing world
AA Kalla, M Tikly
Best Practice & Research Clinical Rheumatology 17 (5), 863-875, 2003
1422003
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study
M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ...
Annals of the rheumatic diseases 75 (1), 163-169, 2016
1392016
Lupus in the developing world–is it any different?
M Tikly, SV Navarra
Best Practice & Research Clinical Rheumatology 22 (4), 643-655, 2008
1372008
Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus.
M Rudwaleit, M Tikly, M Khamashta, K Gibson, J Klinke, G Hughes, ...
The Journal of Rheumatology 23 (10), 1725-1728, 1996
1151996
Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus
R Benitha, M Tikly
Clinical rheumatology 26, 24-29, 2007
1102007
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ...
Annals of the rheumatic diseases 75 (7), 1285-1292, 2016
992016
Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans.
RE Tager, M Tikly
Rheumatology 38 (5), 397-400, 1999
981999
Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations
M Tikly, S Burgin, P Mohanlal, A Bellingan, J George
Clinical rheumatology 15, 143-147, 1996
961996
Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis
V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ...
Arthritis & rheumatology 71 (9), 1553-1570, 2019
942019
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis
MMTM Ally, B Hodkinson, PWA Meyer, E Musenge, M Tikly, R Anderson
Mediators of inflammation 2013, 2013
842013
The clinical utility of accelerometry in patients with rheumatoid arthritis
A Prioreschi, B Hodkinson, I Avidon, M Tikly, JA McVeigh
Rheumatology 52 (9), 1721-1727, 2013
782013
The system can't perform the operation now. Try again later.
Articles 1–20